Literature DB >> 21380783

Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer.

Ozkan Saydam1, Mertol Gokce, Ali Kilicgun, Ozgur Tanriverdi.   

Abstract

The purpose of this study was to explore the accuracy of (18)F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in the assessment of mediastinal lymph node in coal workers who had non-small cell lung cancer. We retrospectively reviewed 42 retired coal workers who had lung cancer without distant metastasis, between May 2007 and May 2010. Regarding the mediastinal lymph nodes, when the standard uptake value was greater than 2.5, it was considered "malignancy positive." After histological examination of the mediastinal lymph nodes, anthracotic and metastatic ones were detected. The results of PET/CT were analyzed to determine its accuracy. Of these 42 patients, PET/CT detected 47 positive mediastinal lymph nodes in 24 patients with a mean SUV maximum of 6.2 (2.6-13.8). One hundred and thirty-one mediastinal lymph node foci were dissected. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of FDG-PET/CT in detecting nodal metastases were 84% (16/19), 65% (15/23), 66% (16/24), 83% (15/18), and 74% (31/42) on a per-patient basis, respectively. Mediastinal node staging with FDG-PET/CT in coal workers is insufficient due to the high false-positive rates due to the presence of pneumoconiosis. In these patients, an invasive technique such as mediastinoscopy seems mandatory for confirmation of ipsilateral or contralateral mediastinal lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380783     DOI: 10.1007/s12032-011-9879-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

1.  Improvement of non-small-cell lung cancer staging by means of positron emission tomography.

Authors:  J M Albes; R Lietzenmayer; U Schott; E Schülen; M Wehrmann; G Ziemer
Journal:  Thorac Cardiovasc Surg       Date:  1999-02       Impact factor: 1.827

2.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

Review 3.  Pneumoconiosis: comparison of imaging and pathologic findings.

Authors:  Semin Chong; Kyung Soo Lee; Myung Jin Chung; Joungho Han; O Jung Kwon; Tae Sung Kim
Journal:  Radiographics       Date:  2006 Jan-Feb       Impact factor: 5.333

Review 4.  Management of unresectable stage III non-small-cell lung cancer with combined-modality therapy: a review of the current literature and recommendations for treatment.

Authors:  Neil A Bayman; Fiona Blackhall; Pooja Jain; Lip Lee; Nick Thatcher; Corinne Faivre-Finn
Journal:  Clin Lung Cancer       Date:  2008-03       Impact factor: 4.785

5.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Authors:  Sung Shine Shim; Kyung Soo Lee; Byung-Tae Kim; Myung Jin Chung; Eun Jung Lee; Joungho Han; Joon Young Choi; O Jung Kwon; Young Mog Shim; Seonwoo Kim
Journal:  Radiology       Date:  2005-07-12       Impact factor: 11.105

6.  Pneumoconiosis-related lung cancers: preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis.

Authors:  M Katabami; H Dosaka-Akita; K Honma; Y Saitoh; K Kimura; Y Uchida; H Mikami; Y Ohsaki; Y Kawakami; K Kikuchi
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

7.  Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.

Authors:  Carolyn E Reed; David H Harpole; Katherine E Posther; Sandra L Woolson; Robert J Downey; Bryan F Meyers; Robert T Heelan; Homer A MacApinlac; Sin-Ho Jung; Gerard A Silvestri; Barry A Siegel; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

8.  Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.

Authors:  Jun Konishi; Koichi Yamazaki; Eriko Tsukamoto; Nagara Tamaki; Yuya Onodera; Toshiyuki Otake; Toshiaki Morikawa; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Masaharu Nishimura
Journal:  Respiration       Date:  2003 Sep-Oct       Impact factor: 3.580

9.  A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Authors:  R Rosell; J Gómez-Codina; C Camps; J Maestre; J Padille; A Cantó; J L Mate; S Li; J Roig; A Olazábal
Journal:  N Engl J Med       Date:  1994-01-20       Impact factor: 91.245

Review 10.  Clinical applications of PET in oncology.

Authors:  Eric M Rohren; Timothy G Turkington; R Edward Coleman
Journal:  Radiology       Date:  2004-03-24       Impact factor: 11.105

View more
  5 in total

1.  The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.

Authors:  Eun Kyoung Choi; Hye Lim Park; Ie Ryung Yoo; Seung Joon Kim; Young Kyoon Kim
Journal:  Eur Radiol       Date:  2019-07-23       Impact factor: 5.315

2.  CT differentiation of enlarged mediastinal lymph node due to anthracosis from metastatic lymphadenopathy: a comparative study proven by endobronchial US-guided transbronchial needle aspiration.

Authors:  Johannes Kirchner; Michael Broll; Phillip Müller; Natalia Pomjanski; Stepfan Biesterfeld; Dieter Liermann; Ralph Kickuth
Journal:  Diagn Interv Radiol       Date:  2015 Mar-Apr       Impact factor: 2.630

Review 3.  Economic Benefits and Diagnostic Quality of Diffusion-Weighted Magnetic Resonance Imaging for Primary Lung Cancer.

Authors:  Katsuo Usuda; Aika Funazaki; Ryo Maeda; Atsushi Sekimura; Nozomu Motono; Munetaka Matoba; Hidetaka Uramoto
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-10-04       Impact factor: 1.520

4.  Assessment of intrathoracic lymph nodes by FDG PET/CT in patients with asbestos-related lung cancer.

Authors:  Norichika Iga; Hiroshi Sonobe; Daisuke Mizuno; Hideyuki Nishi
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

5.  First case of lung cancer with pneumoconiosis and endobronchial leiomyoma complicating the diagnosis.

Authors:  Yutaka Takahara; Kouichi Yamamura; Nozomu Motono; Taku Oikawa; Hidetaka Uramoto; Shiro Mizuno
Journal:  BMC Pulm Med       Date:  2021-09-08       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.